Cargando…
The molecular profile of luminal B breast cancer
Molecular profiling studies have found that estrogen receptor-positive (ER+) human breast cancers are comprised of at least two distinct diseases with differing biologies. With the advent of DNA microarrays, global gene expression patterns were used to define the luminal A and luminal B subtypes of...
Autor principal: | Creighton, Chad J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3430090/ https://www.ncbi.nlm.nih.gov/pubmed/22956860 http://dx.doi.org/10.2147/BTT.S29923 |
Ejemplares similares
-
Luminal-B breast cancer and novel therapeutic targets
por: Tran, Ben, et al.
Publicado: (2011) -
Molecular heterogeneity of luminal breast cancer
por: Loi, S
Publicado: (2011) -
MRI texture analysis in differentiating luminal A and luminal B breast cancer molecular subtypes - a feasibility study
por: Holli-Helenius, Kirsi, et al.
Publicado: (2017) -
Genomic Profiling Shows Increased Glucose Metabolism in Luminal B Breast Cancer
por: Ueda, Shigeto, et al.
Publicado: (2013) -
Profiling of alternative polyadenylation sites in luminal B breast cancer using the SAPAS method
por: WANG, XINMEI, et al.
Publicado: (2015)